OpenBilldrug price receipt

NADAC week of 2026-10-14

ANNOVERA VAGINAL RING

FDA nonproprietary name: segesterone acetate and ethinyl estradiol

For 1 ring

Pharmacies pay

$2,315.29 filed

1 × $2,315.28568 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$2,250.63 filed

1 × $2,250.627 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

0.97× estimated

Medicare paid about what pharmacies pay.

Part D averages every strength and form sold under “Annovera” / “Segesterone Ac/Ethin Estradiol” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$2,667.58 estimated

$2,315.29 + $347.29 (15%) + $5.00 fee per fill = $2,667.58

This is a model, not a price any pharmacy quoted. Shipping is not included. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

ANNOVERA VAGINAL RING is how the CMS NADAC file names this product. The FDA NDC Directory lists it as segesterone acetate and ethinyl estradiol, under the trade name “Annovera”.

FDA gives its dosage form as ring and its route as vaginal.

The labeler, the company named on the label, is Mayne Pharma.

FDA lists it under 2 Established Pharmacologic Classes: Estrogen and Progestin.

The NADAC file of 2026-10-14 prices it under one NDC (National Drug Code), 68308-0752-01.

NADAC classes it as a brand-name drug (rate-setting class B), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2,315.29 for 1 ring (1 × $2,315.28568 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The NDC

Compared with its class

Its NADAC price is $2,315.28568 per EA filed.

Of the 104 other products in FDA’s Estrogen class priced per EA, 0 have a higher middle NADAC price and 104 a lower one. The one in the middle is LYLLANA 0.075 MG PATCH, at $8.11285 per EA filed (eff. 2026-09-23).

Of the 65 other products in FDA’s Progestin class priced per EA, 0 have a higher middle NADAC price and 65 a lower one. The one in the middle is NORETHIN-ETH ESTRAD 1 MG-5 MCG, at $0.57994 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $2,250.63 for 1 ring, at an average of $2,250.627 per EA in 2024 (2024-01-01 to 2024-12-31) for “Annovera” and “Segesterone Ac/Ethin Estradiol”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 40 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for ANNOVERA VAGINAL RING labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Annovera / Segesterone Ac/Ethin Estradiol: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Why does this page start at 1 ring?
NADAC prices this product per EA, and the FDA NDC Directory lists its NDC as dosage form “RING” with route “VAGINAL”. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. So the card starts at 1 ring, priced per ring, rather than guess how many make up a fill; change it to match your prescription.